Private equity Ardian gains control of Neopharmed Gentili

Italian economic-financial daily Il Sole 24 Ore has reported today that Mediulanum Farmaceutici has sold its subsidiary Neopharmed Gentili to private equity Ardian. Neopharmed in 2017 generated sales of €192m.

(Source Il Sole24Ore)